Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Neonatal Screening in Europe Revisited: An ISNS Perspective on the Current State and Developments Since 2010

JG. Loeber, D. Platis, RH. Zetterström, S. Almashanu, F. Boemer, JR. Bonham, P. Borde, I. Brincat, D. Cheillan, E. Dekkers, D. Dimitrov, R. Fingerhut, L. Franzson, U. Groselj, D. Hougaard, M. Knapkova, M. Kocova, V. Kotori, V. Kozich, A....

. 2021 ; 7 (1) : . [pub] 20210305

Language English Country Switzerland

Document type Journal Article

Neonatal screening (NBS) was initiated in Europe during the 1960s with the screening for phenylketonuria. The panel of screened disorders ("conditions") then gradually expanded, with a boost in the late 1990s with the introduction of tandem mass spectrometry (MS/MS), making it possible to screen for 40-50 conditions using a single blood spot. The most recent additions to screening programmes (screening for cystic fibrosis, severe combined immunodeficiency and spinal muscular atrophy) were assisted by or realised through the introduction of molecular technologies. For this survey, we collected data from 51 European countries. We report the developments between 2010 and 2020 and highlight the achievements reached with the progress made in this period. We also identify areas where further progress can be made, mainly by exchanging knowledge and learning from experiences in neighbouring countries. Between 2010 and 2020, most NBS programmes in geographical Europe matured considerably, both in terms of methodology (modernised) and with regard to the panel of conditions screened (expanded). These developments indicate that more collaboration in Europe through European organisations is gaining momentum. We can only accomplish the timely detection of newborn infants potentially suffering from one of the many rare diseases and take appropriate action by working together.

Arbes Health Care Centre Yerevan 0014 Armenia

Center for Preventive Paediatrics 3022 Limassol Cyprus

Centre for Inherited Metabolic Diseases Karolinska University Hospital and Department of Molecular Medicine and Surgery Karolinska Institute SE 17 76 Stockholm Sweden

Centre for Medical Genetics 08661 Vilnius Lithuania

Centre for Population Research National Institue for Public Health and the Environment 3720BA Bilthoven The Netherlands

Child and Adolescent Health Department 06430 Ankara Turkey

Children's Clinic 1083 Budapest Hungary

Children's University Hospital 1004 Riga Latvia

CHU Domaine du Sart Tilman 4000 Liège Belgium

Clinical and Diagnostic Center Pharmbiotest LLC 93000 Rubizhne Ukraine

Department Genetics and Molecular Medicine Landspitali Reykjavik 108 Iceland

Department of Newborn Screening Institute of Child Health 11527 Athens Greece

Department of Pediatrics and Adolescent Medicine 1090 Vienna Austria

Department of Pediatrics and Inherited Metabolic Disorders Charles University 1st Faculty of Medicine and General University Hospital Prague 12808 Czech Republic

Department of Pediatrics University Clinical Centre Tuzla 75000 Bosnia and Herzegovina

Groupement Hospitalier Est 69500 Bron France

Institute for Sick Children 81000 Podgorica Montenegro

Institute of Mother and Child 01 211 Warsaw Poland

International Society for Neonatal Screening Office 3721CK Bilthoven The Netherlands

Laboratoire National de Santé 3555 Dudelange Luxembourg

Málaga Regional University Hospital Institute of Biomedical Research IBIMA 29011 Málaga Spain

Mater Dei Hospital Tal Qroqq Msida MSD2090 Msida Malta

Medical Faculty 1000 Skopje North Macedonia

Medical Faculty University of Tartu 50411 Tart Estonia

Meyer Hospital 50139 Florence Italy

Mother and Child Health Care Institute of Serbia Belgrade 11070 Serbia

National Centre Health and Reproductive and Medical Genetics 2062 Chisinau Moldova

National Genetic Laboratory Hospital Maichin Dom 1431 Sofia Bulgaria

National Institute for Mother and Child Health 050474 Bucharest Romania

National Institute of Health 4000 055 Porto Portugal

Neonatal Screening Center 115580 Moscow Russia

Neonatal Screening Laboratory Children's Hospital CH 8032 Zürich Switzerland

NeugoGenetic and Metabolic Center Tbilisi 0194 Georgia

Newborn Blood Spot Screening Laboratory Dublin 1 Ireland

Newborn Screening Centre Banska Bystrica 97401 Slovakia

Newborn Screening Centre Turku University Hospital 20521 Turku Finland

Newborn Screening Laboratories Tel HaShomer 52621 Ramat Gan Israel

Norwegian National Unit for Newborn Screening 0424 Oslo Norway

Republican Center Mother and Child Screening Tashkent 100164 Uzbekistan

Republican Scientific Centre for Gynaecology and Perinatology Almaty 050020 Kazakhstan

Sheffield Children's NHS Foundation Trust Sheffield S10 2TH UK

Staten Serum Institute 2300 Copenhagen Denmark

University Children's Hospital 1000 Ljubljana Slovenia

University Clinic 04103 Leipzig Germany

University Clinical Centre Pristina 10000 Kosovo

University Hospital Medical Centre Zagreb 10000 Zagreb Croatia

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc21018219
003      
CZ-PrNML
005      
20210729104153.0
007      
ta
008      
210726s2021 sz f 000 0|eng||
009      
AR
024    7_
$a 10.3390/ijns7010015 $2 doi
035    __
$a (PubMed)33808002
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Loeber, J Gerard $u International Society for Neonatal Screening (ISNS) Office, 3721CK Bilthoven, The Netherlands
245    10
$a Neonatal Screening in Europe Revisited: An ISNS Perspective on the Current State and Developments Since 2010 / $c JG. Loeber, D. Platis, RH. Zetterström, S. Almashanu, F. Boemer, JR. Bonham, P. Borde, I. Brincat, D. Cheillan, E. Dekkers, D. Dimitrov, R. Fingerhut, L. Franzson, U. Groselj, D. Hougaard, M. Knapkova, M. Kocova, V. Kotori, V. Kozich, A. Kremezna, R. Kurkijärvi, G. La Marca, R. Mikelsaar, T. Milenkovic, V. Mitkin, F. Moldovanu, U. Ceglarek, L. O'Grady, M. Oltarzewski, RD. Pettersen, D. Ramadza, D. Salimbayeva, M. Samardzic, M. Shamsiddinova, J. Songailiené, I. Szatmari, N. Tabatadze, B. Tezel, A. Toromanovic, I. Tovmasyan, N. Usurelu, P. Vevere, L. Vilarinho, M. Vogazianos, R. Yahyaoui, M. Zeyda, PCJI. Schielen
520    9_
$a Neonatal screening (NBS) was initiated in Europe during the 1960s with the screening for phenylketonuria. The panel of screened disorders ("conditions") then gradually expanded, with a boost in the late 1990s with the introduction of tandem mass spectrometry (MS/MS), making it possible to screen for 40-50 conditions using a single blood spot. The most recent additions to screening programmes (screening for cystic fibrosis, severe combined immunodeficiency and spinal muscular atrophy) were assisted by or realised through the introduction of molecular technologies. For this survey, we collected data from 51 European countries. We report the developments between 2010 and 2020 and highlight the achievements reached with the progress made in this period. We also identify areas where further progress can be made, mainly by exchanging knowledge and learning from experiences in neighbouring countries. Between 2010 and 2020, most NBS programmes in geographical Europe matured considerably, both in terms of methodology (modernised) and with regard to the panel of conditions screened (expanded). These developments indicate that more collaboration in Europe through European organisations is gaining momentum. We can only accomplish the timely detection of newborn infants potentially suffering from one of the many rare diseases and take appropriate action by working together.
655    _2
$a časopisecké články $7 D016428
700    1_
$a Platis, Dimitris $u Department of Newborn Screening, Institute of Child Health, 11527 Athens, Greece
700    1_
$a Zetterström, Rolf H $u Centre for Inherited Metabolic Diseases, Karolinska University Hospital and Department of Molecular Medicine and Surgery, Karolinska Institute, SE-17 76 Stockholm, Sweden
700    1_
$a Almashanu, Shlomo $u Newborn Screening Laboratories, Tel-HaShomer, 52621 Ramat Gan, Israel
700    1_
$a Boemer, François $u CHU-Domaine du Sart Tilman, 4000 Liège, Belgium
700    1_
$a Bonham, James R $u Sheffield Children's NHS Foundation Trust, Sheffield S10 2TH, UK
700    1_
$a Borde, Patricia $u Laboratoire National de Santé, 3555 Dudelange, Luxembourg
700    1_
$a Brincat, Ian $u Mater Dei Hospital, Tal-Qroqq Msida, MSD2090 Msida, Malta
700    1_
$a Cheillan, David $u Groupement Hospitalier Est, 69500 Bron, France
700    1_
$a Dekkers, Eugenie $u Centre for Population Research, National Institue for Public Health and the Environment (RIVM), 3720BA Bilthoven, The Netherlands
700    1_
$a Dimitrov, Dobry $u National Genetic Laboratory, Hospital Maichin Dom, 1431 Sofia, Bulgaria
700    1_
$a Fingerhut, Ralph $u Neonatal Screening Laboratory, Children's Hospital, CH-8032 Zürich, Switzerland
700    1_
$a Franzson, Leifur $u Department Genetics & Molecular Medicine, Landspitali, Reykjavik 108, Iceland
700    1_
$a Groselj, Urh $u University Children's Hospital, 1000 Ljubljana, Slovenia
700    1_
$a Hougaard, David $u Staten Serum Institute, 2300 Copenhagen, Denmark
700    1_
$a Knapkova, Maria $u Newborn Screening Centre, Banska Bystrica 97401, Slovakia
700    1_
$a Kocova, Mirjana $u Medical Faculty, 1000 Skopje, North Macedonia
700    1_
$a Kotori, Vjosa $u University Clinical Centre, Pristina 10000, Kosovo
700    1_
$a Kozich, Viktor $u Department of Pediatrics and Inherited Metabolic Disorders, Charles University-First Faculty of Medicine and General University Hospital, Prague 12808, Czech Republic
700    1_
$a Kremezna, Anastasiia $u Clinical and Diagnostic Center "Pharmbiotest", LLC 93000 Rubizhne, Ukraine
700    1_
$a Kurkijärvi, Riikka $u Newborn Screening Centre, Turku University Hospital, 20521 Turku, Finland
700    1_
$a La Marca, Giancarlo $u Meyer Hospital, 50139 Florence, Italy
700    1_
$a Mikelsaar, Ruth $u Medical Faculty, University of Tartu, 50411 Tart, Estonia
700    1_
$a Milenkovic, Tatjana $u Mother and Child Health Care Institute of Serbia, Belgrade 11070, Serbia
700    1_
$a Mitkin, Vyacheslav $u Neonatal Screening Center, 115580 Moscow, Russia
700    1_
$a Moldovanu, Florentina $u National Institute for Mother and Child Health, 050474 Bucharest, Romania
700    1_
$a Ceglarek, Uta $u University Clinic, 04103 Leipzig, Germany
700    1_
$a O'Grady, Loretta $u Newborn Blood Spot Screening Laboratory, Dublin 1, Ireland
700    1_
$a Oltarzewski, Mariusz $u Institute of Mother and Child, 01-211 Warsaw, Poland
700    1_
$a Pettersen, Rolf D $u Norwegian National Unit for Newborn Screening, 0424 Oslo, Norway
700    1_
$a Ramadza, Danijela $u University Hospital Medical Centre Zagreb, 10000 Zagreb, Croatia
700    1_
$a Salimbayeva, Damilya $u Republican Scientific Centre for Gynaecology and Perinatology, Almaty 050020, Kazakhstan
700    1_
$a Samardzic, Mira $u Institute for Sick Children, 81000 Podgorica, Montenegro
700    1_
$a Shamsiddinova, Markhabo $u Republican Center Mother and Child Screening, Tashkent 100164, Uzbekistan
700    1_
$a Songailiené, Jurgita $u Centre for Medical Genetics, 08661 Vilnius, Lithuania
700    1_
$a Szatmari, Ildiko $u Children's Clinic, 1083 Budapest, Hungary
700    1_
$a Tabatadze, Nazi $u NeugoGenetic and Metabolic Center, Tbilisi 0194, Georgia
700    1_
$a Tezel, Basak $u Child and Adolescent Health Department, 06430 Ankara, Turkey
700    1_
$a Toromanovic, Alma $u Department of Pediatrics, University Clinical Centre, Tuzla 75000, Bosnia and Herzegovina
700    1_
$a Tovmasyan, Irina $u Arbes Health Care Centre, Yerevan 0014, Armenia
700    1_
$a Usurelu, Natalia $u National Centre Health and Reproductive & Medical Genetics, 2062 Chisinau, Moldova
700    1_
$a Vevere, Parsla $u Children's University Hospital, 1004 Riga, Latvia
700    1_
$a Vilarinho, Laura $u National Institute of Health, 4000-055 Porto, Portugal
700    1_
$a Vogazianos, Marios $u Center for Preventive Paediatrics, 3022 Limassol, Cyprus
700    1_
$a Yahyaoui, Raquel $u Málaga Regional University Hospital. Institute of Biomedical Research IBIMA, 29011 Málaga, Spain
700    1_
$a Zeyda, Maximilian $u Department of Pediatrics and Adolescent Medicine, 1090 Vienna, Austria
700    1_
$a Schielen, Peter C J I $u International Society for Neonatal Screening (ISNS) Office, 3721CK Bilthoven, The Netherlands
773    0_
$w MED00205983 $t International journal of neonatal screening $x 2409-515X $g Roč. 7, č. 1 (2021)
856    41
$u https://pubmed.ncbi.nlm.nih.gov/33808002 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20210726 $b ABA008
991    __
$a 20210729104152 $b ABA008
999    __
$a ind $b bmc $g 1676579 $s 1138663
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2021 $b 7 $c 1 $e 20210305 $i 2409-515X $m International journal of neonatal screening $n Int. j. neonatal screen. $x MED00205983
LZP    __
$a Pubmed-20210726

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...